The big question is whether triple agonism can improve both glucose and weight strongly enough while preserving tolerability
Endometrial function in women with polycystic ovary syndrome: a comprehensive review
"Semaglutide: a review in type 2 diabetes and obesity." Drugs
Back Flint, A, Raben, A, Astrup, A, Holst, JJ (1 Feb 1998) 'Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans', The Journal of Clinical Investigation , 101/3, 515-20
Week 4 and beyond: Maintenance For those whose symptoms have resolved or significantly improved, you can gradually resume dose escalation if you had stepped down
Downregulation of the kidney glucagon receptor, essential for renal function and systemic homeostasis, contributes to chronic kidney disease